These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan. Ito N, Hataya H, Saida K, Amano Y, Hidaka Y, Motoyoshi Y, Ohta T, Yoshida Y, Terano C, Iwasa T, Kubota W, Takada H, Hara T, Fujimura Y, Ito S. Clin Exp Nephrol; 2016 Apr; 20(2):265-72. PubMed ID: 26156042 [Abstract] [Full Text] [Related]
23. Atypical hemolytic uremic syndrome: Consensus of diagnosis and treatment in Taiwan. Tseng MH, Lin SH, Tsai JD, Wu MS, Tsai IJ, Chen YC, Chang MC, Chou WC, Chiou YH, Huang CC. J Formos Med Assoc; 2023 May; 122(5):366-375. PubMed ID: 36323601 [Abstract] [Full Text] [Related]
40. Atypical HUS due to factor H antibodies in an adult patient successfully treated with eculizumab. Green H, Harari E, Davidovits M, Blickstein D, Grossman A, Gafter U, Gafter-Gvili A. Ren Fail; 2014 Aug; 36(7):1119-21. PubMed ID: 24828571 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]